Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.
The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.
The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.